azidopyridine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 10964472 |
| SCHEMBL ID | 16040152 |
| MeSH ID | M0533334 |
| Synonym |
|---|
| 2-azido-pyridine |
| 2-azidopyridine , |
| 39910-65-1 |
| 10.14272/DIABUJYZLNKYQJ-UHFFFAOYSA-N |
| doi:10.14272/diabujyzlnkyqj-uhfffaoysa-n |
| AKOS017516136 |
| DIABUJYZLNKYQJ-UHFFFAOYSA-N |
| 2-pyridinyl azide |
| azidopyridine |
| SCHEMBL16040152 |
| DTXSID80449938 |
| EN300-222853 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.47) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||